BMS 200 mg 6672
Generic Name: didanosine
Pill imprint BMS 200 mg 6672 has been identified as Videx EC 200 MG.
Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy.
Videx EC 200 MG is not subject to the Controlled Substances Act.
See also related documents.
Videx EC Images
- Generic Name:
- didanosine
- Imprint:
-
BMS 200 mg 6672
- Strength:
- 200 MG
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- carboxymethylcellulose sodium
diethyl phthalate
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium hydroxide
sodium starch glycolate type A potato
magnesium silicate
gelatin
titanium dioxide
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6672
Advertisement
More VIDEX EC resources
- Videx EC Delayed-Release Enteric-Coated Capsules (Wolters Kluwer)
- Videx EC (Cerner Multum)
- Videx EC (Micromedex) - Includes Dosage Information
- Videx EC (FDA)
Search Again
